GNMX $0.20 +0.01 (0.45%)
Wed, Jan 16, 2019
Aevi Genomic Medicine, Inc. - Common Stock is a Health Care stock that trades on the NASDAQ with a market cap of $10 Million
Medgenics (known as Aevi Genomic Medicine since December 2016) is a clinical-stage biopharmaceutical company involved mainly in genomic medicine. Genomic medicine involves the usage of individual's genomic information to decide upon clinical care. This medical discipline is used in the fields of oncology, pharmacology, rare and undiagnosed diseases, and infectious diseases. Medgenics' partner is the Center for Applied Genomics at the Children's Hospital of Philadelphia, with which it works to develop drugs by implementing genomics medicine. The firm's portfolio includes TARGT, for treatment of end-stage renal disease; ÃŽÂ²-thalassemia intermedia (Thalassemia patients require blood transfusion); and other developments. http://www.aevigenomics.com
Aevi Genomic Medicine, Inc. - Common Stock Stock Charts
GNMX Stock Price
Below are a few key dates for the stock price.
Year To Date
The most recent stock price is $0.20.
The Year To Date (YTD) return is -74.03%.
52 Week Low
The 52 Week Low stock price is $0.19 set on Thu, Jan 3, 2019 which is 13 days ago.
The current price per share is 5.26% above the 52 week low.
52 Week High
The 52 Week High stock price is $2.39 set on Mon, Feb 12, 2018 which is 338 days ago.
The current price per share is -91.63% below the 52 week high.
All Time High
The All Time High stock price is $6.85 set on Fri, Dec 16, 2016 which is 761 days ago.
The current price per share is -97.08% below the all time high.
GNMX Stock Split History
Aevi Genomic Medicine, Inc. - Common Stock has had 0 stock splits.
Below is the EPS, P/E Ratio and Earnings Date.
The EPS is -$0.12 and the P/E Ratio is 0.
A negative Earnings Per Share (EPS) means that this company is losing money and not profitable at this time.
Stocks can make big percentage moves on the earnings announcement.
Companies announce earnings either before the market open or after the close.
The Earnings Release Date for Aevi Genomic Medicine, Inc. - Common Stock was Thu, Aug 2, 2018.
Since this earnings release 167 days ago, the stock price is down by -81.82%.
Many investors know the importance of a companies earnings report. Also, the market reaction to the earnings release can be even more important and can help in making a prediction of a future price forecast of the shares.
A significant post earnings announcement percentage move can continue or reverse an existing trend for several days or weeks after the earnings date.
The most recent Earnings Release Date was on Thu, Nov 1, 2018, which was 76 days ago.
Since this earnings date, the stock price is down by -83.33%.
Aevi Genomic Medicine, Inc. - Common Stock Dividend
Below is important Dividend information.
GNMX currently does not pay a dividend.
You may like this list of best dividend stocks of 2019.
Below are some other Biotech & Pharma industry stocks like Aevi Genomic Medicine, Inc. - Common Stock.